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Abstract—The current studies examined the mechanisms of neutrophil recruitment
into the rat peritoneal cavity following injection of glycogen and into rat lungs
following alveolar deposition of IgA immune complexes or airway instillation of
phorbol ester (PMA). Unexpectedly, in each model a requirement for L-arginine
for neutrophil recruitment was demonstrated, since administration of the L-arginine
analogue, NG-monomethyl L-arginine acetate (L-NMA), greatly reduced neutrophil
accumulation as assessed by quantitation of neutrophils in peritoneal exudates and
bronchoalveolar lavage fluids, and by lung myeloperoxidase content. In the case of
IgA immune complex deposition, lung recruitment of neutrophils was also suppressed
by soluble recombinant human complement receptor-1 (sCRl) and antibody to CD 18
but not by antibody to E-selectin. In contrast, neutrophil accumulation following
airway instillation of PMA exhibited, surprisingly, no requirement for complement
but requirements for both E-selectin and CD 18, These data demonstrate variable
requirements for complement, E-selectin and CD 18 but a consistent requirement for
L-arginine for neutrophil recruitment. These findings provide evidence suggesting that
L-arginine or its derivatives regulate neutrophil recruitment.
INTRODUCTION
Recruitment of leukocytes into sites of inflammation has been extensively
studied in vivo, including the use of antibodies that block leukocyte adhesion
molecules. In general, blockade of B2 integrins with antibody to CD 18 is effec-
tive in inhibiting the recruitment of neutrophils into skin and lung following the
local injection of proinflammatory mediators, living bacteria or bacterial lipo-
polysaccharide (1, 2). The requirement for CD18 is not invariable, since neu-
trophil accumulation in rabbit lungs in response to Streptococcal pneumoniae
is apparently CDlS-independent, in contrast to findings with Escherichia coli
327
0360-3997/98/0600-0327$15.00/0 C1998 Plenum Publishing Corporation
(2). The accepted process for neutrophil adhesion and transmigration includes
the initial tethering of leukocytes by selectins and firm adhesion and transmigra-
tion mediated by interactions between leukocyte integrins and endothelial cell
adhesion molecules of the immunoglobulin superfamily (3).
There is increasing evidence that L-arginine or its derivatives have impor-
tant effects on leukocyte recruitment and on tissue injury. L-arginine can be
metabolized by a variety of different cells to form nitric oxide (4). Nitric oxide
(•NO) or its derivatives (peroxynitrite anion, ONOO, and the hydroxyl radical,
HO-) appear to be highly toxic to cells and tissues, and the blocking of -NO gen-
eration in vivo is protective against IgG immune complex-induced lung injury
(5-7). Similar to prostacyclin, -NO has been shown to inhibit the adhesion of
leukocytes to endothelial cells (8, 9). However, superoxide anion (O2), by inter-
acting with -NO to generate ONOO, can scavenge -NO, thereby reversing the
anti-adhesive effects of -NO (9).
In the current studies we investigated determinants of neutrophil recruit-
ment into the rat peritoneal cavity following instillation of glycogen and into
the lung following deposition of IgA immune complexes or after airway instil-
lation of phorbol ester. As assessed by the use of the L-arginine analog, NG-
monomethyl-L-arginine acetate (L-NMA), the data suggest a consistent require-
ment for L-arginine in the tissue accumulation of neutrophils, while requirements
for complement, E-selectin and CD 18 are variable among different inflammatory
models.
MATERIALS AND METHODS
Materials. Oyster glycogen, phorbol 12-myristate 13-acetate (PMA) and L-arginine were
obtained from Sigma Chemical Company (St. Louis, Missouri). L-NMA was obtained from Cal-
biochem (LaJolla, California). Soluble complement receptor-1 (sCRl) was produced by CHO cells
transfected with the human cDNA for sCRl and was kindly provided by Dr. Una Ryan (T Cell Sci-
ences, Cambridge, Massachusetts). Murine monoclonal IgA antibody to dinitrophenol (DNP) as well
as murine IgA that was non-reactive with DNP were obtained by implanting murine plasmacytomas,
MOPC 460 and 315 (Litton Bionetics, Kingston, Maryland), respectively, into Balb/c mice (Jackson
Laboratories, Bar Harbor, Maine), followed by collection of the ascites fluids. The IgA was then
isolated and purified as previously described (10, 11). Conjugates of DNP to bovine serum albumin
(BSA) were prepared such that the final preparation contained 50 DNP groups per molecule BSA.
Models of Inflammation. Specific pathogen-free male Long-Evans rats (Charles River Lab-
oratories, Portage, Michigan) weighing 300-350 grams were used in all experiments. Anesthesia
was induced with intraperitoneal ketamine (100 mg/kg) prior to all experimental manipulations.
Glycogen-induced peritonitis was produced by intraperitoneal injection of 25 ml of 0.1% (wt/vol)
oyster glycogen. Negative control rats received an equal volume of saline. Four h after injection,
peritoneal exudates were collected and the cellular content analyzed by conventional microcytome-
try. Peritoneal exudates contained >95% neutrophils. IgA immune complex-induced alveolitis was
Mulligan, Lentsch, and Ward328
produced by intratracheal instillation of 1.2 mg anti-DNP IgA (in a total volume of 300 ul PBS)
followed immediately by intravenous injection of 3.3 mg (in 0.5 ml PBS) DNP-BSA. Intravenous
injection of DNP-BSA was omitted in negative control rats. Four h later, rats were sacrificed by
exsanguination and lung tissues or bronchoalveolar lavage (BAL) fluids harvested for analysis.
PMA-induced lung alveolitis was produced by intratracheal administration of 15 ug PMA in 300
H\ PBS as previously described (12). Negative control rats received 300 ul PBS intratracheally.
Four h later, rats were sacrificed by exsanguination and lung tissues or BAL fluids harvested for
analysis.
Interventions. L-NMA was administered intraperitoneally with glycogen, or intratracheally
with IgA antibodies or PMA, at a final concentration of 5 mM in the volumes indicated above.
This dose of L-NMA has been shown to significantly reduce the level of NO2 and NO3 in BAL
fluids during immune complex-induced lung inflammation (7). Hemolysis of red blood cells was
blocked by sCRl in the presence of human or rat serum and sCRl blocks rat complement with an
ICso of approximately 150 pM (13). We administered sCRl intravenously (15 mg/kg) 2, 2.5 and 3
h after induction of the inflammatory reactions. This dose of sCRl is known to reduce IgG immune
complex-induced lung neutrophil accumulation (14). Anti-rat E-selectin (clone CL-3) was generated
as described previously (15). F(ab')2 preparations were made using Immunopure F(ab'h (Pierce
Co., Rockford, Illinois) and 45 ug were administered intravenously 2.5, 3 and 3.5 h after induc-
tion of injury. This dose of anti-E-selectin substantially reduced IgG immune complex-induced lung
neutrophil accumulation (15). Anti-rat CD18 (clone CL-26) was generated as previously described
(16). F(ab')a preparations were made and 33 mg were administered intravenously 2.5, 3 and 3.5 h
after induction of injury. This dose of anti-CD 18 greatly reduces neutrophil buildup in the model of
IgG immune complex-induced lung injury (16). F(ab' h preparations of a mouse myeloma irrelevant
IgGi (MOPC-21) served as the control for anti-CD18 and anti-E-selectin preparations.
Lung MPO Content. Whole lung MPO activity was quantitated as described previously (17).
Briefly, whole lungs homogenates were diluted in 50 mM potassium phosphate buffer containing
0.5% hexadecyltrimethylammonium bromide (pH, 6.0). After sonication and twice freeze-thawed,
samples were centrifuged at 4000 x g for 30 min. The supematants were reacted with H2O2 (0.3
mM) in the presence of O-dianisidine. MPO activity was assessed by measuring the rate of change
in absorbance at 460 nm.
BAL Neutrophil Counts. BAL fluids were collected by instilling and withdrawing 5 ml of
sterile PBS five times from the lungs via an intratracheal cannula. Neutrophils were identified and
quantitated by microcytometry.
Statistical Analyses. All values are expressed as mean ± SEM. Data were analyzed with a
one-way analysis of variance and individual group means were then compared with a Tukey's test.
Differences were considered significant when P < 0.05. For calculations of percent change, negative
control values were subtracted from positive control and treatment group values.
RESULTS
Requirement for L-Arginine in Glycogen-Induced Peritoneal Exudates. Rats
received intraperitoneal glycogen in the presence or absence of 5 mM L-NMA
with or without 20 mM L-arginine. Peritoneal exudates were harvested 4 h later
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Fig. 1. Effects of L-NMA on peritoneal neutrophil accumulation during glycogen-induced peritoni-
tis. Peritoneal exudates were harvested 4 h after intraperitoneal injection of PBS, glycogen, glycogen
with 5 mM L-NMA, or glycogen with 5 mM L-NMA and 20 mM L-arginine. For each group, N =
6.
and the number of neutrophils in the exudates determined. In rats injected with
PBS, few neutrophils were observed in peritoneal exudates, whereas glycogen
injection resulted in significant neutrophil accumulation (2.0 x 108) (Figure 1).
When glycogen was injected in the presence of 5 mM L-NMA, there was a 34%
reduction (P < 0.05) in numbers of peritoneal neutrophils. However, when 20
mM L-arginine was co-administered with L-NMA, there was no reduction in the
number of neutrophils in the exudates. These findings suggest that glycogen-
induced peritoneal neutrophil accumulation is, at least in part, dependent on a
requirement for L-arginine.
Requirements for L-Arginine for Neutrophil Recruitment during IgA Immune
Complex-Induced Alveolitis. Effects of L-NMA on neutrophil accumulation
induced by IgA immune complexes were assessed over a 4 h time course (Fig-
ure 2). IgA immune complex deposition resulted in progressive neutrophil accu-
mulation in BAL fluids. Coadministration of L-NMA did not reduce neutrophil
influx at the 1 h time point, but decreased neutrophil accumulation was found
at 2, 3 and 4 h, with reductions of 38%, 50%, and 57%, respectively (P < 0.01).
Lung MPO content was measured as another index of lung neutrophil accu-
mulation. As shown in Figure 3, the presence of 5 mM L-NMA reduced lung
MPO content at 4 h by 53% (P < 0.05), confirming the data in Figure 2. When
20 mM L-arginine was present with L-NMA, the inhibitory effects of L-NMA on
neutrophil accumulation were lost (Figure 3). There was no effect of L-arginine
alone on IgA immune complex-induced lung content of MPO. These data indi-
cate that L-NMA suppresses neutrophil accumulation in lung during IgA immune
complex-induced inflammation.
Effects of Complement and Adhesion Molecule Blockade on Neutrophil
Recruitment During IgA Immune Complex-Induced Alveolitis. In order to deter-
mine whether complement and adhesion molecules contribute to neutrophil
recruitment into lungs containing IgA immune complexes, rats were treated with
sCRl, anti-E-selectin or anti-CD 18 during the course of lung injury. As shown in
Figure 4, treatment with sCRl reduced IgA immune complex-induced increases
in BAL neutrophil counts by 79% (P < 0.01). Treatment with anti-E-selectin
had no effect on IgA immune complex-induced neutrophil recruitment, but treat-
ment with anti-CD 18 reduced neutrophil accumulation by 62% (P < 0.05) (Fig-
ure 4). Similar effects were observed when lung MPO content was measured
(data not shown), indicating that in response to IgA immune complex-induced
Fig. 2. Effects of L-NMA on BAL neutrophil counts after intrapulmonary deposition of IgA immune
complexes. BAL neutrophils from rats developing deposits of IgA immune complexes (closed cir-
cles) or IgA immune complexes in the presence of 5 mM L-NMA (open circles) were quantitated
at the times indicated. When L-NMA was used, it was given intratracheally together with the IgA
anti-DNP-BSA. For each group, N = 4.
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Fig. 3. Effects of L-NMA and/or L-arginine on lung MPO content after intrapulmonary deposition
of IgA immune complexes. For each group, N = 6.
Fig. 4. Effects of sCRl, anti-E-selectin and anti-CD18 on BAL neutrophil counts after intrapul-
monary deposition of IgA immune complexes. For each group, N = 5.
lung inflammation, complement and B2 integrins, but not E-selectin are required
for neutrophil recruitment.
Requirements for L-Arginine for Neutrophil Recruitment into PMA-lnjured
Lungs. Effects of L-NMA on neutrophil accumulation during PMA-induced lung
injury was assessed over a 4 h time course (Figure 5). Lung instillation of PMA
caused progressive increases in BAL neutrophil counts. Coadministration of L-
NMA with PMA did not reduce the number of neutrophils recovered in BAL
fluids 1 h after PMA instillation, but decreased neutrophil recruitment was found
at 2, 3 and 4 h, with reductions of 63%, 73% and 70%, respectively (P < 0.01).
Measurement of lung MPO content again confirmed BAL neutrophil counts as
cotreatment with L-NMA reduced lung MPO values by 97% (P < 0.01) at 4h
(Figure 6). The addition of 20 mM L-arginine with the L-NMA, reversed the
inhibitory effect of L-NMA. L-arginine alone had no effect on PMA-induced
increases in lung MPO content. Thus, it appears that L-arginine is required for
the recruitment of neutrophils in PMA injured lung.
Effects of Complement and Adhesion Molecule Blockade on Neutrophil
Recruitment into PMA-lnjured Lung. In PMA-injured lung, blockade of corn-
Fig. S. Effects of L-NMA on BAL neutrophil counts after intratracheal instillation of PMA. BAL
neutrophils from rats receiving PMA (closed circles) or PMA and 5 mM L-NMA (open circles) were
quantitated at the times indicated. For each group, N = 4.
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Fig. 6. Effects of L-NMA and/or L-arginine on lung MPO content after intratracheal instillation of
PMA. For each group, N = 6.
plement using sCRl had no effect on neutrophil influx (Figure 7), indicating that
in this model of lung injury complement is not required for neutrophil recruit-
ment. In contrast to IgA immune complex-induced lung injury, increases in BAL
neutrophil counts induced by PMA were reduced by 42% (P < 0.05) by treat-
ment with anti-E-selectin antibody and by 36% (P < 0.05) by treatment with
anti-CD 18 antibody (Figure 7). These data suggest that neutrophil recruitment
to lung in response to PMA is dependent upon both E-selectin and B2 integrins
but not complement.
DISCUSSION
It has been shown during ischemia/reperfusion events in the mesentery, that
infusion of L-NMA or L-NAME causes enhanced neutrophil adhesion to the post-
capillary endothelium (18). In contrast, our studies examining neutrophil recruit-
ment into an inflamed peritoneal cavity or lung have indicated that treatment
with L-NMA causes a substantial reduction in the accumulation of neutrophils
at these two sites. The apparent discrepancies may be explained by the different
models for induction of inflammation, by the different endpoints employed (ex
vivo microscopy versus direct cell counting of retrieved cells or MPO extrac-
tion), or by differences in the vascular beds under study. In the case of the lung,
neutrophil extravasation occurs within the pulmonary capillaries, in contrast to
venules in the mesenteric model of inflammation. Because the capillary diameter
in lung is less than the diameter of the neutrophil, the rolling phenomenon well
described in mesenteric venules cannot occur in pulmonary capillaries, espe-
cially if neutrophils are activated and relatively non-deformable (19). This may
explain the differences noted in effects of L-NMA in mesenteric venules versus
in the lung capillaries. In these various studies, there were also differences in the
protocols for employment of the antagonist of L-arginine. In our studies L-NMA
was injected locally (intraperitoneally or intratracheally), whereas in the studies
involving ischemia-reperfusion the L-arginine analogues were infused directly
into the vascular compartment. These technical differences might account for
the divergent experimental results. It has been suggested that endothelial pro-
duction of -NO suppresses adhesion of neutrophils to activated endothelial cells
and that there is a dynamic balance, such that the presence of O2 will "scav-
enge" -NO, converting it to ONOO~ and therefore removing the regulatory role
of -NO on neutrophil adhesion to endothelial cells (9). It is puzzling why in the
current studies the presence of the L-arginine analog, L-NMA, resulted in reduced
lung MPO content and BAL neutrophils. As pointed out above, it is important to
note that in our experiments L-NMA was given intratracheally, which avoids the
hypertension-inducing effects of intravenously or orally administered analogs of
L-arginine. Alternatively, the different inflammatory conditions may trigger path-
ways that employ fundamentally different pathophysiological responses. Pul-
Fig. 7. Effects of sCRl, anti-E-selectin and anti-CD 18 on BAL neutrophil counts after intratracheal
instillation of PMA. For each group, N = 5.
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monary recruitment of neutrophils appears to be dependent upon the stimulus.
As shown in the current studies, alveolar deposition of IgA immune complexes
or airway instillation of PMA results in neutrophil accumulation that requires L-
arginine. In contrast, in lung injury induced by IgG immune complexes, admin-
istration of L-NMA did not alter neutrophil accumulation in the BAL fluids or
lung MPO content but was nevertheless highly protective (7). These protective
effects of L-NMA in the IgG immune complex model were associated with a
greatly reduced content of NO2 and NO3 in the BAL fluids, suggesting that
injury in this model may be due directly to the generation from L-arginine of
toxic products such as -NO, ONOCT or HO. In the current studies it is clear
that L-arginine or its derivatives somehow positively affect tissue recruitment of
neutrophils, even though in both IgA immune complex- and PMA-induced lung
inflammation influx of neutrophils is unrelated to lung injury (the injury being
linked to the generation of toxic products from lung macrophages) (10-12).
Another finding that may be relevant to differences between pathophysio-
logical events in lungs following deposition of IgG or IgA immune complexes
is that, in the IgG immune complex model, TNFa is abundant in BAL fluids and
blocking of TNFa with antibody sharply reduced neutrophil influx and the extent
of injury (17). In contrast, in the IgA immune complex model of lung injury BAL
fluids contain little if any measurable TNFa, and anti-TNFa is not protective
against injury (20). Thus, neutrophil accumulation in lung following deposition
of IgA immune complexes is independent of a requirement for TNFa, emphasiz-
ing the differences in the mediator pathways related to recruitment of neutrophils
in these two models of lung injury. Similarly, we have been unable to demon-
strate a role for TNFa in neutrophil recruitment induced by airway instillation
of PMA. While mechanisms of lung neutrophil recruitment following deposition
of IgA immune complexes or instillation of PMA share a requirement for L-argi-
nine, divergent roles for complement, E-selectin and GDI8 suggest complicated
networking of pathways leading to intrapulmonary neutrophil recruitment.
The variation in requirements for E-selectin and CD 18 for neutrophil
recruitment into rat lung is not especially surprising, since it has been shown
that neutrophil recruitment into lung can occur via CDlS-dependent as well as
independent pathways (2). At least in the case of the peritoneal cavity, opti-
mal recruitment of neutrophils requires both P-selectin as well as E-selectin. In
studies using P-selectin deficient mice, maximal blockade of neutrophil recruit-
ment into the peritoneal cavity occurred only when antibody to E-selectin was
also administered (21). Thus, there are nuances in factors required for neutrophil
recruitment not only as a function of the organ under study but also as related
to the circumstances of the inflammatory response.
The requirement for L-arginine for neutrophil recruitment may involve a
product of L-arginine metabolism, such as HO, which is ultimately derived from
the interaction of -NO and O2. It has been shown that activation of the alternative
336 Mulligan, Lentsch, and Ward
pathway of the complement system can occur following the generation of HO-,
resulting in activation of C5 and formation of the membrane attack complex (22,
23). Although we observed that complement blockade by sCRl did not interfere
with neutrophil accumulation in PMA-induced lung injury, this does not elimi-
nate the possible involvement of C5 products in the recruitment process, since
there is evidence that HO- may directly interact with C5 to generate an acti-
vated form of C5 (22, 23). This reaction would not be blocked by sCRl since
sCRl only blocks formation of the C3 and C5 convertases and does not cause
consumptive depletion of C5 (13). The requirement for complement pathway
activation in the model of IgA immune complex-induced alveolitis, as demon-
strated by the effects of sCRl, may be explained by the fact that IgA immune
complexes have limited complement activating properties (10) and that it is the
combination of alternative pathway activation (caused by the IgA immune com-
plexes) together with direct interaction of HO- with C5 to generate complement-
dependent chemotactic products that are responsible for neutrophil recruitment.
Complement activation products and adhesion molecules are known to be
necessary for neutrophil recruitment in a number of inflammatory systems (1,2,
14, 15, 24). Other studies show that neutrophil accumulation during glycogen-
induced peritonitis is dependent upon E-selectin and B2 integrins (25). In con-
trast, neutrophil recruitment during IgA immune complex-induced alveolitis
requires complement and B2 integrins, but is independent of E-selectin. In PMA-
induced lung injury, neutrophil accumulation appears to be independent of com-
plement, but shows a requirement for both E-selectin and B2 integrins. The
requirement for CD 18 is consistent with studies of PMA-induced pneumonitis in
rabbits (2). The current report demonstrates the difficulty in predicting the deter-
minants of neutrophil recruitment in vivo and suggest the existence of several
different pathways that lead to tissue accumulation of neutrophils. The consis-
tent ability of L-NMA to suppress neutrophil recruitment in the models studied
suggests that L-arginine or product(s) of its metabolism may play an important
role in the generation of a chemotactic factor or some other phlogistic prod-
uct.
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